{"id":"anti-platelet-therapy","safety":{"commonSideEffects":[{"rate":null,"effect":"Bleeding"},{"rate":null,"effect":"Gastrointestinal hemorrhage"},{"rate":null,"effect":"Dyspepsia"},{"rate":null,"effect":"Bruising"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Anti-platelet agents work by interfering with platelet activation and adhesion through various mechanisms, such as inhibiting cyclooxygenase (aspirin), blocking ADP receptors (P2Y12 inhibitors), or inhibiting phosphodiesterase. By reducing platelet clumping, these drugs decrease the risk of thrombotic complications in cardiovascular and cerebrovascular conditions.","oneSentence":"Anti-platelet therapy inhibits platelet aggregation to prevent blood clots and reduce thrombotic events.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:42:45.394Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acute coronary syndrome"},{"name":"Stroke prevention"},{"name":"Peripheral arterial disease"},{"name":"Post-percutaneous coronary intervention"}]},"trialDetails":[{"nctId":"NCT03574909","phase":"PHASE3","title":"IRELAnD: Investigating the Role of Early Low-dose Aspirin in Diabetes","status":"COMPLETED","sponsor":"Royal College of Surgeons, Ireland","startDate":"2018-09-01","conditions":"Pre-Gestational Diabetes","enrollment":137},{"nctId":"NCT06757764","phase":"PHASE4","title":"The Effect and Safety of Combined Anti-platelet Treatment in Acute Ischemic Stroke Due to Large Artery Atherosclerosis","status":"RECRUITING","sponsor":"Asan Medical Center","startDate":"2025-07-10","conditions":"Cerebral Infarction, Stenosis Artery","enrollment":2340},{"nctId":"NCT03601923","phase":"PHASE2","title":"Niraparib in Patients With Pancreatic Cancer","status":"COMPLETED","sponsor":"Dana-Farber Cancer Institute","startDate":"2018-08-22","conditions":"Pancreatic Cancer","enrollment":32},{"nctId":"NCT07101926","phase":"","title":"Monitoring of Anti-TFPI in Hemophilia","status":"RECRUITING","sponsor":"Hospices Civils de Lyon","startDate":"2025-10-23","conditions":"Hemophilia, Rebalancing Agents, Prophylaxis","enrollment":11},{"nctId":"NCT02875353","phase":"NA","title":"Blood Flow Monitoring to Prevent Post-Polypectomy Induced Ulcer Bleeding","status":"ACTIVE_NOT_RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2017-02-15","conditions":"Delayed Post-Polypectomy Induced Ulcer Hemorrhage","enrollment":180},{"nctId":"NCT06859424","phase":"PHASE2","title":"A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation","status":"RECRUITING","sponsor":"Center for International Blood and Marrow Transplant Research","startDate":"2025-07-25","conditions":"AML (Acute Myelogenous Leukemia), Acute Lymphoid Leukemia (ALL), Acute Leukemia (Category)","enrollment":358},{"nctId":"NCT05047172","phase":"PHASE3","title":"Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Florida","startDate":"2022-08-02","conditions":"Intracranial Arteriosclerosis, Stroke","enrollment":1683},{"nctId":"NCT06070350","phase":"PHASE3","title":"Massive Transfusion in Children-2: A Trial Examining Life Threatening Hemorrhage in Children","status":"RECRUITING","sponsor":"Philip Spinella","startDate":"2024-11-01","conditions":"Hemorrhagic Shock, Trauma Injury","enrollment":1000},{"nctId":"NCT03252249","phase":"PHASE4","title":"Duration of Dual Anti-Platelet Therapy (DUAL-ACS)","status":"COMPLETED","sponsor":"University of Edinburgh","startDate":"2018-12-11","conditions":"Acute Coronary Syndrome, Coronary Artery Disease","enrollment":5094},{"nctId":"NCT07408648","phase":"PHASE2","title":"A Clinical Study on the Efficacy and Safety of Hetrombopag in the Treatment of Thrombocytopenia Induced by Gynecological Tumor Therapy","status":"NOT_YET_RECRUITING","sponsor":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","startDate":"2026-04-15","conditions":"Chemotherapy Induced Thrombocytopenia","enrollment":244},{"nctId":"NCT06158828","phase":"PHASE1, PHASE2","title":"Pilot Study of Memory-like Natural Killer (ML NK) Cells After TCRαβ T Cell Depleted Haploidentical Transplant in AML","status":"RECRUITING","sponsor":"Washington University School of Medicine","startDate":"2024-05-15","conditions":"AML, Childhood, Aml, Acute Myeloid Leukemia, Pediatric","enrollment":68},{"nctId":"NCT03851614","phase":"PHASE2","title":"Study of DNA Damage, Angiogenesis, and PD-L1 Inhibitors in Advanced Solid Tumors","status":"ACTIVE_NOT_RECRUITING","sponsor":"University Health Network, Toronto","startDate":"2019-04-08","conditions":"Mismatch Repair Proficient Colorectal Cancer, Pancreatic Adenocarcinoma, Leiomyosarcoma","enrollment":90},{"nctId":"NCT05718323","phase":"PHASE2","title":"Niraparib Added to Anti-PD-L1 Antibody Maintenance in SLFN11-positive, Extensive-disease SCLC","status":"RECRUITING","sponsor":"ETOP IBCSG Partners Foundation","startDate":"2023-12-20","conditions":"SCLC,Extensive Stage, SLFN11-positive","enrollment":44},{"nctId":"NCT07372326","phase":"NA","title":"A Study on the Effect of Electronic Moxibustion Based on Ziwu Liuzhu in Treating Constipation in Stroke Patients","status":"RECRUITING","sponsor":"The Fourth Affiliated Hospital of Zhejiang University School of Medicine","startDate":"2025-05-15","conditions":"Stroke Patients With Constipation","enrollment":105},{"nctId":"NCT07362966","phase":"PHASE4","title":"Effect of Colchicine on Progression of Coronary Atherosclerosis in Patients With TET2-CHIP Variant","status":"NOT_YET_RECRUITING","sponsor":"Shenyang Northern Hospital","startDate":"2026-02-24","conditions":"Colchicine, Coronary Atherosclerosis Management, Clonal Hematopoiesis of Indeterminate Potential","enrollment":120},{"nctId":"NCT06853535","phase":"PHASE3","title":"Precision Antiplatelet Therapy Guided by Platelet Aggregation Function in Patients With Acute Ischemic STROKE","status":"RECRUITING","sponsor":"Sichuan Provincial People's Hospital","startDate":"2025-05-23","conditions":"Acute Ischemic Stroke, Clopidogrel Resistance","enrollment":5138},{"nctId":"NCT04708587","phase":"NA","title":"Appropriate Duration of Anti-Platelet straTegy in Patients With Advance Chronic Kidney Disease After New Generation Drug Eluting Stents (ADAPT-CKD)","status":"RECRUITING","sponsor":"Yonsei University","startDate":"2021-03-23","conditions":"Chronic Kidney Diseases","enrollment":900},{"nctId":"NCT07339137","phase":"NA","title":"The Effects of Intra-articular and Peri-articular Platelet-rich Plasma (PRP) Injections ın Chronic Knee Osteoarthritis","status":"RECRUITING","sponsor":"Ankara City Hospital Bilkent","startDate":"2025-08-01","conditions":"Platelet Rich Plasma Injection, Ultrasonography, Gonarthrosis","enrollment":42},{"nctId":"NCT04328727","phase":"PHASE2","title":"Combination of Eltrombopag With Immunosuppressive Therapy in East-Asian Patients With Severe Aplastic Anemia","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2020-11-04","conditions":"Severe Aplastic Anemia (SAA)","enrollment":36},{"nctId":"NCT05399693","phase":"","title":"Platelet Transfusion Refractoriness","status":"COMPLETED","sponsor":"Institut de cancérologie Strasbourg Europe","startDate":"2022-02-02","conditions":"Platelet Transfusion Refractoriness","enrollment":50},{"nctId":"NCT07307053","phase":"PHASE1, PHASE2","title":"Rare Tumor Focused Platform Study of Innovative Therapies and Technologies (PLATFORM2)","status":"NOT_YET_RECRUITING","sponsor":"Cancer Institute and Hospital, Chinese Academy of Medical Sciences","startDate":"2026-01-01","conditions":"Rare Malignant Neoplasm, Advanced Solid Tumors, Metastatic Solid Tumors","enrollment":600},{"nctId":"NCT02302547","phase":"PHASE3","title":"Trial to Evaluate the Interest of a Reductive Anti Retroviral Strategy Using Dual Therapy Inspite of Triple Therapy","status":"COMPLETED","sponsor":"University Hospital, Tours","startDate":"2014-12","conditions":"HIV","enrollment":224},{"nctId":"NCT05171842","phase":"","title":"Dissection of the Superior Mesenteric Artery","status":"COMPLETED","sponsor":"First Affiliated Hospital of Zhejiang University","startDate":"2021-09-09","conditions":"Dissection of the Superior Mesenteric Artery","enrollment":136},{"nctId":"NCT05466201","phase":"PHASE2, PHASE3","title":"The Use of Eltrombopag Post HSCT in BMFD","status":"COMPLETED","sponsor":"The First Affiliated Hospital of Soochow University","startDate":"2022-10-22","conditions":"Stem Cell Transplant Complications","enrollment":118},{"nctId":"NCT04624854","phase":"PHASE4","title":"Dual Anti-Platelet Therapy in Patients With Coronary Multi-Vessel Disease (DAPT-MVD)","status":"COMPLETED","sponsor":"Harbin Medical University","startDate":"2020-10-28","conditions":"Coronary Artery Disease, Myocardial Ischemia, Acute Coronary Syndrome","enrollment":8250},{"nctId":"NCT06857045","phase":"NA","title":"Comparison Three vs Six Months of Dual Anti-platelet Therapy After Sirolimus-eluting Stent Implantation","status":"WITHDRAWN","sponsor":"Sino Medical Sciences Technology Inc.","startDate":"2024-07-09","conditions":"Intracranial Arteriosclerosis, Intracranial Artery Stenosis, Drug-Eluting Stents","enrollment":""},{"nctId":"NCT03378934","phase":"PHASE4","title":"Anti-platelet Effect of Berberine in Patients After Percutaneous Coronary Intervention","status":"RECRUITING","sponsor":"Peking Union Medical College Hospital","startDate":"2018-09-26","conditions":"Coronary Artery Disease, Percutaneous Coronary Intervention","enrollment":64},{"nctId":"NCT07064707","phase":"PHASE2","title":"Rupatadine in Patients With Ulcerative Colitis","status":"RECRUITING","sponsor":"Alexandria University","startDate":"2025-07-15","conditions":"Ulcerative Colitis","enrollment":60},{"nctId":"NCT05120726","phase":"PHASE4","title":"A Novel Therapeutic Treatment of Pyoderma Gangrenosum","status":"TERMINATED","sponsor":"Louisiana State University Health Sciences Center in New Orleans","startDate":"2021-06-02","conditions":"Pyoderma Gangrenosum","enrollment":5},{"nctId":"NCT03124329","phase":"NA","title":"Efficacy of Methods to Treat Multiple Gingival Recession Defects","status":"WITHDRAWN","sponsor":"University of Southern California","startDate":"2017-05-01","conditions":"Gingival Recession","enrollment":""},{"nctId":"NCT07169513","phase":"NA","title":"Mechanistic Study of Anti-Platelet Therapy in Atherosclerosis","status":"NOT_YET_RECRUITING","sponsor":"Guy's and St Thomas' NHS Foundation Trust","startDate":"2025-10-01","conditions":"Peripheral Arterial Disease, Silent Atherosclerosis","enrollment":60},{"nctId":"NCT06737380","phase":"PHASE1","title":"UC-MSC Cell Therapy Study for Systemic Lupus Erythematosus (SLE) Patients","status":"RECRUITING","sponsor":"LiveKidney.Bio","startDate":"2025-01-07","conditions":"SLE, Lupus, Systemic Lupus Erthematosus","enrollment":10},{"nctId":"NCT06638151","phase":"PHASE2","title":"Clopidogrel Plus Aspirin in Acute Ischemic Stroke Following Thrombectomy and/or Intravenous Thrombolysis (CoPrime)","status":"RECRUITING","sponsor":"University of Alberta","startDate":"2025-09-02","conditions":"Acute Ischemic Stroke","enrollment":200},{"nctId":"NCT07162519","phase":"NA","title":"Romiplostim N01 in the Treatment of Thrombocytopenia Caused by Cytotoxic Drugs in Breast Cancer Patients","status":"NOT_YET_RECRUITING","sponsor":"Tianjin Medical University Cancer Institute and Hospital","startDate":"2025-09-20","conditions":"Cytotoxic Drugs, Romiplostim N01, Breast Cancer","enrollment":68},{"nctId":"NCT05476991","phase":"PHASE3","title":"Evaluation of Low Dose Colchicine and Ticagrelor in Prevention of Ischemic Stroke in Patients With Stroke Due to Atherosclerosis","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2023-05-17","conditions":"Stroke, Stroke, Ischemic, Atherosclerosis","enrollment":2800},{"nctId":"NCT05877027","phase":"NA","title":"Exercise vs. Topical Diclofenac vs. PRP","status":"COMPLETED","sponsor":"Istanbul University - Cerrahpasa","startDate":"2024-03-20","conditions":"Gonarthrosis","enrollment":82},{"nctId":"NCT06783868","phase":"","title":"Assessing the Neurological Outcomes After Atrial Fibrillation Ablation for Rhythm Control","status":"NOT_YET_RECRUITING","sponsor":"Kansas City Heart Rhythm Research Foundation","startDate":"2025-10","conditions":"Atrial Fibrillation, Stroke","enrollment":100},{"nctId":"NCT05907629","phase":"","title":"Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis- Magnetic Resonance Imaging","status":"RECRUITING","sponsor":"Yale University","startDate":"2024-06-24","conditions":"Stroke, Intracranial Atherosclerotic Stenosis (ICAS)","enrollment":300},{"nctId":"NCT07138144","phase":"PHASE4","title":"Efficacy, Safety, and ToLerability of Switching to A Two-Drug Regimen With DTG/3TC Compared to Maintaining A Three-Drug REgimen With BIC/FTC/TAF or DTG/3TC/ABC in ViroLogically SupprEssed PeopLe Living With HIV After 24 and 48 Weeks of Follow-Up","status":"RECRUITING","sponsor":"José Antonio Mata Marín","startDate":"2025-07-12","conditions":"HIV Infections","enrollment":156},{"nctId":"NCT07129031","phase":"PHASE3","title":"Optimization Strategies for Blood Transfusion Protocols in the Emergency Treatment of Hemorrhagic Shock","status":"NOT_YET_RECRUITING","sponsor":"Xijing Hospital","startDate":"2025-09-01","conditions":"Hemorrhage, Hemorrhagic Shock, Upper Gastrointestinal Bleeding (UGIB)","enrollment":180},{"nctId":"NCT06898151","phase":"NA","title":"Carotid Endarterectomy and Stenting Timing","status":"RECRUITING","sponsor":"Xuanwu Hospital, Beijing","startDate":"2025-03-07","conditions":"Carotid Endarterectomy, Carotid Stenting","enrollment":268},{"nctId":"NCT06650553","phase":"NA","title":"Umbilical Cord Blood-Supported Haplo-HSCT for Aplastic Anemia Treatment Study","status":"RECRUITING","sponsor":"Shanxi Bethune Hospital","startDate":"2024-06-01","conditions":"Aplastic Anemias","enrollment":110},{"nctId":"NCT04483583","phase":"PHASE4","title":"Tailoring P2Y12 Inhibiting Therapy in Patients Requiring Oral Anticoagulation After PCI","status":"COMPLETED","sponsor":"University of Florida","startDate":"2020-12-08","conditions":"Coronary Artery Disease","enrollment":81},{"nctId":"NCT07094178","phase":"NA","title":"Corticosteroid Versus PRP Injections for Shoulder Tendinopathy","status":"RECRUITING","sponsor":"Hopital Charles Nicolle","startDate":"2025-06-30","conditions":"Tendinopathy of Rotator Cuff","enrollment":60},{"nctId":"NCT03939637","phase":"PHASE3","title":"Eltrombopag vs Standard Front Line Management for Newly Diagnosed Immune Thrombocytopenia (ITP) in Children","status":"COMPLETED","sponsor":"Baylor College of Medicine","startDate":"2019-05-02","conditions":"Immune Thrombocytopenia","enrollment":122},{"nctId":"NCT04753749","phase":"NA","title":"Evaluation of a Modified Anti-Platelet Therapy Associated With Low-dose DES Firehawk in Acute Myocardial Infarction Patients Treated With Complete Revascularization Strategy","status":"COMPLETED","sponsor":"MicroPort CRM","startDate":"2021-03-25","conditions":"Myocardial Infarction, Acute, Coronary Artery Disease","enrollment":2248},{"nctId":"NCT05394285","phase":"PHASE2","title":"A Clinical Study of Hetrombopag Olamine Tablets for Thrombocytopenia Induced by Anti-tumor Treatment in Advanced Breast Cancer","status":"RECRUITING","sponsor":"Henan Cancer Hospital","startDate":"2022-08-19","conditions":"Breast Cancer","enrollment":60},{"nctId":"NCT07031063","phase":"PHASE4","title":"Safety, Tolerability and Effectiveness of DTG/3TC vs BIC/TAF/FTC in PWH Without Antiretroviral Experience","status":"RECRUITING","sponsor":"Instituto Mexicano del Seguro Social","startDate":"2025-04-01","conditions":"HIV Infection, Metabolic Syndrome, Antiretroviral Treatment","enrollment":124},{"nctId":"NCT06744777","phase":"PHASE3","title":"The Comparative Efficacy of Standard Treatment Plus Ribavirin vs Standard Treatment Alone in Preventing Clinically Significant Hemorrhage in Patients With Dengue Fever","status":"COMPLETED","sponsor":"Khyber Medical University Peshawar","startDate":"2024-12-17","conditions":"Dengue Fever, Dengue Hemorrhagic Fever, Severe Dengue","enrollment":284},{"nctId":"NCT06101667","phase":"NA","title":"Efficacy and Safety of Endovascular Recanalization for Acute Basilar Artery Occlusion With Extended Time Window (ANGEL-BAO)","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2023-10-15","conditions":"Acute Ischemic Stroke, Basilar Artery Occlusion","enrollment":224},{"nctId":"NCT01333046","phase":"PHASE1","title":"Administration of TAA-Specific CTLs; Hodgkin or Non-Hodgkin Lymphoma; TACTAL","status":"ACTIVE_NOT_RECRUITING","sponsor":"Baylor College of Medicine","startDate":"2012-01","conditions":"Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Hodgkin Disease","enrollment":36},{"nctId":"NCT05996393","phase":"PHASE4","title":"CsA+ATG+AVA vs. CsA+AVA for the Treatment of Newly-diagnosed SAA in the Elderly","status":"COMPLETED","sponsor":"Peking Union Medical College Hospital","startDate":"2023-09-15","conditions":"Aplastic Anemia","enrollment":86},{"nctId":"NCT05567562","phase":"PHASE2","title":"Anti-Platelets in Chronic Obstructive Pulmonary Disease","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2024-03-27","conditions":"COPD, Emphysema, Emphysema or COPD","enrollment":19},{"nctId":"NCT06449469","phase":"NA","title":"The Nordic Aortic Valve Intervention Trial 4 (NOTION-4)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Rigshospitalet, Denmark","startDate":"2021-05-01","conditions":"Aortic Valve Stenosis, Cardiovascular Diseases, Heart Diseases","enrollment":352},{"nctId":"NCT06907056","phase":"PHASE4","title":"Effectiveness and Safety of Darunavir/Cobicistat Plus Lamivudine Versus Darunavir/Cobicistat Plus Tenofovir/Emtricitabine in Virologically Suppressed HIV-1-positive Individuals in Mexico","status":"RECRUITING","sponsor":"José Antonio Mata Marín","startDate":"2023-11-09","conditions":"HIV Infection","enrollment":138},{"nctId":"NCT05947175","phase":"NA","title":"Vertebral Bone Marrow Clot for Spinal Surgery","status":"RECRUITING","sponsor":"Istituto Ortopedico Rizzoli","startDate":"2023-05-19","conditions":"Degenerative Spine Diseases","enrollment":96},{"nctId":"NCT03746054","phase":"PHASE3","title":"Evaluation of a Cardiovascular Active Prevention in Chronic Myeloid Leukemia on the Cardiovascular Morbi-mortality","status":"TERMINATED","sponsor":"University Hospital, Angers","startDate":"2019-12-20","conditions":"Chronic Myeloid Leukemia (CML)","enrollment":80},{"nctId":"NCT05068414","phase":"","title":"Assessment of the Incidence of Hemorrhagic and Ischemic Events in Post-angioplasty in Anticoagulated Coronary Patients with Atrial Fibrillation","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire de Nīmes","startDate":"2021-04-12","conditions":"Atrial Fibrillation, Acute Coronary Syndrome, Thrombosis","enrollment":122},{"nctId":"NCT03245489","phase":"PHASE1","title":"Anti-platelet + Pembro for H&N Tumors","status":"COMPLETED","sponsor":"Medical University of South Carolina","startDate":"2018-03-06","conditions":"Head and Neck Cancer","enrollment":20},{"nctId":"NCT06792643","phase":"PHASE2","title":"Cangrelor on Top of anticoagUlation in Patients With myocaRdial Infarction-related Cardiogenic Shock/Cardiac Arrest receiVIng VA-ECMO","status":"RECRUITING","sponsor":"IRCCS San Raffaele","startDate":"2024-04-01","conditions":"Cardiogenic Shock, Extracorporeal Membrane Oxygenation Complication, Platelet Dysfunction","enrollment":50},{"nctId":"NCT06790888","phase":"NA","title":"Ripertamab Plus Eltrombopag vs. Eltrombopag in ITP Patients Post-Steroid Failure","status":"NOT_YET_RECRUITING","sponsor":"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","startDate":"2025-02","conditions":"ITP - Immune Thrombocytopenia","enrollment":78},{"nctId":"NCT04250116","phase":"PHASE4","title":"Appropriate Duration of Anti-Platelet and Thrombotic Strategy After 12 Months in Patients With Atrial Fibrillation Treated With Drug Eluting Stents","status":"ACTIVE_NOT_RECRUITING","sponsor":"Yonsei University","startDate":"2020-04-28","conditions":"Atrial Fibrillation","enrollment":960},{"nctId":"NCT03606642","phase":"PHASE2","title":"SYNergy Stent® System Implantation With Mandatory Intra-VascularUltra-Sound Guidance and Dual Anti-Platelet Therapy","status":"TERMINATED","sponsor":"HonorHealth Research Institute","startDate":"2018-11-19","conditions":"Coronary Artery Disease, Atherosclerosis, Stent Placement","enrollment":50},{"nctId":"NCT03752216","phase":"PHASE4","title":"NIraparib and Quality of LifE is a Longitudinal Study Evaluating in Real Life the Tolerability of Niraparib.","status":"COMPLETED","sponsor":"ARCAGY/ GINECO GROUP","startDate":"2019-04-03","conditions":"Ovarian Cancer","enrollment":141},{"nctId":"NCT04844619","phase":"PHASE1","title":"KDR2-2 Suspension Eyedrop in the Treatment of Neovascular Glaucoma (KDR-NVG) Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2021-04-19","conditions":"Neovascular Glaucoma, Neovascularization","enrollment":40},{"nctId":"NCT06694168","phase":"NA","title":"Efficacy of the Entire Papilla Preservation Technique With and Without the Use of L-PRF as a Regenerative Material for the Treatment of Infrabony Defects","status":"RECRUITING","sponsor":"Universidad de los Andes, Chile","startDate":"2024-08-27","conditions":"Periodontal Regeneration, Minimally Invasive Surgical Technique, Platelet Rich Fibrin","enrollment":30},{"nctId":"NCT03876457","phase":"NA","title":"SELECT2: A Randomized Controlled Trial to Optimize Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke","status":"COMPLETED","sponsor":"University Hospitals Cleveland Medical Center","startDate":"2019-10-11","conditions":"Acute Ischemic Stroke","enrollment":352},{"nctId":"NCT06696807","phase":"","title":"Immunomodulatory Therapy & VSA","status":"COMPLETED","sponsor":"Dao Wen Wang","startDate":"2018-10-01","conditions":"Vasospastic Angina","enrollment":71},{"nctId":"NCT06676410","phase":"PHASE2","title":"Clinical Trial to Evaluate the Efficacy and Safety of Codivir® in Addition to Standard Antiretroviral Treatment for HIV Infection in Antiretroviral-naïve Participants","status":"RECRUITING","sponsor":"Code Pharma","startDate":"2023-07-20","conditions":"HIV, HIV Infection","enrollment":40},{"nctId":"NCT06642207","phase":"","title":"Effect of IL17 Inhibitor in Comparison With Anti-TNF in Patients With Ankylosing Spondylitis","status":"RECRUITING","sponsor":"Sohag University","startDate":"2024-10-01","conditions":"Ankylosing Spondylitis","enrollment":50},{"nctId":"NCT03947229","phase":"PHASE4","title":"A Randomized Comparison of CLOpidogrel Monotherapy Versus Extended Dual-antiplatelet Therapy Beyond 12 Months After Implantation of Drug-eluting StEnts in High-risk Lesions or Patients; A-CLOSE Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"Yonsei University","startDate":"2019-08-14","conditions":"Coronary Artery Disease, DES","enrollment":3200},{"nctId":"NCT06650826","phase":"","title":"Study Regarding the Incidence of Anti-platelet Factor 4-antibodies in Patients Aged 18 to 60 Years With Spontaneous or Infection- or Vaccine-associated or Recurrent Venous and/or Arterial Thrombosis","status":"RECRUITING","sponsor":"Cardioangiologisches Centrum Bethanien","startDate":"2024-07-01","conditions":"Arterial or Venous Thrombosis","enrollment":200},{"nctId":"NCT04076423","phase":"PHASE4","title":"A Phase IV Study to Assess the Impact of the Change of Antiretroviral Treatment From Dual Therapy to Triple Therapy on Inflammation in Patients With HIV Infection","status":"COMPLETED","sponsor":"Fundacion SEIMC-GESIDA","startDate":"2019-10-10","conditions":"HIV Infections","enrollment":141},{"nctId":"NCT02513914","phase":"NA","title":"Operative Procedures Vs. Endovascular Neurosurgery for Untreated Pseudotumor Trial","status":"SUSPENDED","sponsor":"St. Joseph's Hospital and Medical Center, Phoenix","startDate":"2020-06-03","conditions":"Pseudotumor Cerebri, Idiopathic Intracranial Hypertension (IIH)","enrollment":80},{"nctId":"NCT06453291","phase":"NA","title":"Assessment of Different Clinical Techniques to Treat Patients With Chronic Low Back Pain","status":"RECRUITING","sponsor":"Iffat Anwar Medical Complex","startDate":"2024-07-10","conditions":"Chronic Low Back Pain (CLBP)","enrollment":100},{"nctId":"NCT06331169","phase":"PHASE1","title":"Anlotinib With Trastuzumab Deruxtecan for Previously Treated HER2-Low Advanced Breast Cancer","status":"RECRUITING","sponsor":"Fudan University","startDate":"2024-07-31","conditions":"Breast Cancer","enrollment":42},{"nctId":"NCT06550752","phase":"PHASE1, PHASE2","title":"Erectile Dysfunction Treatment Using Stem Cells","status":"NOT_YET_RECRUITING","sponsor":"COR clinic of Regenerative Medicine","startDate":"2024-08-10","conditions":"Erectile Dysfunction","enrollment":30},{"nctId":"NCT05718856","phase":"PHASE4","title":"TPO-RAs Combining Anti-CD 20 Monoclonal Antibody Versus TPO-RAs in the Management of Pediatric Primary Immune Thrombocytopenia (ITP)","status":"UNKNOWN","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2023-02-23","conditions":"Primary Immune Thrombocytopenia (ITP)","enrollment":166},{"nctId":"NCT02016170","phase":"NA","title":"Pharmacodynamic Evaluation of Switching From Prasugrel to Ticagrelor","status":"COMPLETED","sponsor":"University of Florida","startDate":"2014-03","conditions":"Coronary Artery Disease, Acute Coronary Syndrome","enrollment":82},{"nctId":"NCT05070260","phase":"PHASE2, PHASE3","title":"ACTISAVE: ACuTe Ischemic Stroke Study Evaluating Glenzocimab Used as Add-on Therapy Versus placEbo","status":"COMPLETED","sponsor":"Acticor Biotech","startDate":"2021-09-23","conditions":"Acute Ischemic Stroke","enrollment":438},{"nctId":"NCT06470477","phase":"","title":"Molecular Characteristics of Phlegm-heat Syndrome in Ischemic Stroke","status":"NOT_YET_RECRUITING","sponsor":"Dongzhimen Hospital, Beijing","startDate":"2024-06-20","conditions":"Ischemic Stroke, Acute","enrollment":84},{"nctId":"NCT04240834","phase":"PHASE4","title":"Ticagrelor With Low-dose Versus Regular Aspirin in Patients With Acute Coronary Syndrome (ACS) at High-Risk for Ischemia After Percutaneous Coronary Intervention","status":"RECRUITING","sponsor":"Fu Wai Hospital, Beijing, China","startDate":"2021-02-01","conditions":"Acute Coronary Syndrome, Interventional Cardiology","enrollment":1220},{"nctId":"NCT04625907","phase":"PHASE1, PHASE2","title":"FaR-RMS: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma","status":"RECRUITING","sponsor":"University of Birmingham","startDate":"2020-09-17","conditions":"Rhabdomyosarcoma","enrollment":1672},{"nctId":"NCT01556659","phase":"NA","title":"LV Thrombus After Acute AMI: A Randomized Controlled Trial","status":"TERMINATED","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2012-03","conditions":"Ventricular Thrombosis Mural Following Myocardial Infarction","enrollment":25},{"nctId":"NCT05673135","phase":"NA","title":"The Outcomes of Hypertension in Obese Versus Non-obese Pregnant Women","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2025-04-01","conditions":"Hypertension in Pregnancy","enrollment":260},{"nctId":"NCT04989127","phase":"","title":"Comparison The Postoperative Effects of Local and Systemic Antibiotics Applied With Platelets Rich Fibrin","status":"COMPLETED","sponsor":"Ceren Melahat Donmezer","startDate":"2019-03-17","conditions":"Impacted Wisdom Tooth","enrollment":75},{"nctId":"NCT02932501","phase":"","title":"Medication-related Osteonecrosis of the Jaw (MRONJ) Registry","status":"ACTIVE_NOT_RECRUITING","sponsor":"AO Clinical Investigation and Publishing Documentation","startDate":"2017-08-14","conditions":"Medication-related Osteonecrosis of the Jaw, Bisphosphonate-Associated Osteonecrosis of the Jaw","enrollment":518},{"nctId":"NCT05581238","phase":"","title":"Validation of a Red Blood Cell Transfusion Prediction Model in a Low Transfusion Rate Population.","status":"COMPLETED","sponsor":"Medisch Spectrum Twente","startDate":"2022-11-01","conditions":"Platelet Aggregation, Blood Transfusion","enrollment":6428},{"nctId":"NCT03896321","phase":"NA","title":"Coronary Artery Ectasia in Elective Coronary Angiography : Predictors, Outcomes and Management","status":"COMPLETED","sponsor":"Assiut University","startDate":"2019-12-01","conditions":"Ectasia, Coronary Artery Disease","enrollment":79},{"nctId":"NCT04051203","phase":"PHASE1","title":"Ultrasound Guided Platelet Rich Plasma Injections for Post Traumatic Greater Occipital Neuralgia","status":"COMPLETED","sponsor":"University of Calgary","startDate":"2019-02-01","conditions":"Occipital Neuralgia, Headache","enrollment":35},{"nctId":"NCT01651208","phase":"NA","title":"Improving Adherence to Post PCI Antiplatelet Therapy in Minority Populations","status":"COMPLETED","sponsor":"University of Miami","startDate":"2010-01","conditions":"Coronary Artery Disease","enrollment":452},{"nctId":"NCT04409834","phase":"PHASE4","title":"Prevention of Arteriovenous Thrombotic Events in Critically-Ill COVID-19 Patients Trial","status":"COMPLETED","sponsor":"The TIMI Study Group","startDate":"2020-08-05","conditions":"COVID-19, Venous Thromboembolism, Arterial Thrombosis","enrollment":390},{"nctId":"NCT06198673","phase":"","title":"A Prospective muLticEnter Registry in chrONic coronARy synDrOme","status":"NOT_YET_RECRUITING","sponsor":"University of Roma La Sapienza","startDate":"2024-01-01","conditions":"Coronary Artery Disease","enrollment":1000},{"nctId":"NCT06071091","phase":"NA","title":"Permanent Intracranial Stenting for Acute Ischemic Stroke Related to a Refractory Large Vessel Occlusion","status":"ACTIVE_NOT_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2023-11-08","conditions":"Acute Ischemic Stroke","enrollment":346},{"nctId":"NCT06196398","phase":"","title":"Effects of Medical Treatment of ICAS With Hemodynamic Disorders Based on MR-FFR","status":"UNKNOWN","sponsor":"Xuanwu Hospital, Beijing","startDate":"2023-01-01","conditions":"Stroke, Ischemic, Intracranial Atherosclerosis","enrollment":400},{"nctId":"NCT06080256","phase":"PHASE3","title":"Extra Alirocumab in Addition to Statin Therapy in Asymptomatic Intracranial Atherosclerotic Stenosis (EAST-aICAS)","status":"UNKNOWN","sponsor":"The First Affiliated Hospital with Nanjing Medical University","startDate":"2023-12-30","conditions":"Intracranial Atherosclerosis, Atherosclerotic Plaque, Stenosis","enrollment":80},{"nctId":"NCT06126367","phase":"","title":"Assessment of Lipoprotein(a) and Endogenous Fibrinolysis in Atherosclerotic Cardiovascular Disease/Aortic Valve Disease","status":"RECRUITING","sponsor":"East and North Hertfordshire NHS Trust","startDate":"2023-10-20","conditions":"Atherosclerosis, Aortic Valve Disease","enrollment":180},{"nctId":"NCT06107140","phase":"","title":"Duration of Dual Antiretroviral Therapy in Virologically Suppressed People Living With HIV and Factors Associated With Switching to Tritherapy : a Real-life Cohort","status":"COMPLETED","sponsor":"Tourcoing Hospital","startDate":"2011-01-01","conditions":"HIV Infections","enrollment":580},{"nctId":"NCT02668562","phase":"NA","title":"Timing of Coronary Artery Bypass Surgery Among Patients With Acute Coronary Syndromes Initially on Ticagrelor","status":"COMPLETED","sponsor":"Ottawa Heart Institute Research Corporation","startDate":"2016-02","conditions":"Acute Coronary Syndrome","enrollment":143},{"nctId":"NCT06088433","phase":"PHASE4","title":"Ticagrelor Single Antiplatelet Therapy in Patients With High Risk of Bleeding After DCB for Coronary Small Vessel Disease","status":"UNKNOWN","sponsor":"Fu Wai Hospital, Beijing, China","startDate":"2023-11-15","conditions":"Coronary Heart Disease","enrollment":292}],"_emaApprovals":[],"_faersSignals":[{"count":1,"reaction":"ABDOMINAL PAIN"},{"count":1,"reaction":"ASTHENIA"},{"count":1,"reaction":"CEREBROVASCULAR DISORDER"},{"count":1,"reaction":"CHRONIC KIDNEY DISEASE"},{"count":1,"reaction":"CHRONIC OBSTRUCTIVE PULMONARY DISEASE"},{"count":1,"reaction":"COLITIS ISCHAEMIC"},{"count":1,"reaction":"CONVULSION"},{"count":1,"reaction":"DEFAECATION URGENCY"},{"count":1,"reaction":"DEHYDRATION"},{"count":1,"reaction":"DRUG HYPERSENSITIVITY"}],"_approvalHistory":[],"publicationCount":1199,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Anti-platelet therapy","genericName":"Anti-platelet therapy","companyName":"Boston Scientific Corporation","companyId":"boston-scientific-corporation","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Anti-platelet therapy inhibits platelet aggregation to prevent blood clots and reduce thrombotic events. Used for Acute coronary syndrome, Stroke prevention, Peripheral arterial disease.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}